e-learning
resources
London 2016
Tuesday, 06.09.2016
Early life origins of asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
What are the common biological mechanisms that lead to obstructive airway disease?
Fernando D. Martinez (Tucson, United States of America)
Source:
International Congress 2016 – Early life origins of asthma and COPD
Session:
Early life origins of asthma and COPD
Session type:
Lunchtime session
Number:
4456
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Fernando D. Martinez (Tucson, United States of America). What are the common biological mechanisms that lead to obstructive airway disease?. International Congress 2016 – Early life origins of asthma and COPD
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
The role of cluster analysis in defining phenotypes of obstructive airway diseases: is there a need for a new taxonomy of obstructive airway diseases?
Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD
Year: 2011
The lung microbiome in obstructive airways disease: potential pathogenetic roles
Source: Eur Respir Monogr 2019; 83: 140-157
Year: 2019
Multiple inflammatory hits and the pathogenesis of severe airway disease
Source: Eur Respir J 2006; 27: 884-888
Year: 2006
Possible mechanisms underlying the development of cachexia in COPD
Source: Eur Respir J 2008; 31: 492-501
Year: 2008
Understanding the different physiology behind breathlessness due to obstructive and restrictive lung diseases
Source: Annual Congress 2009 - PG10 Self management in chronic respiratory disease
Year: 2009
Is pesticide exposure a cause of obstructive airways disease?
Source: Eur Respir Rev 2014; 23:180-192
Year: 2014
Defining severe obstructive lung disease in the biologic era: an endotype-based approach
Source: Eur Respir J, 54 (5) 1900108; 10.1183/13993003.00108-2019
Year: 2019
Defining airflow limitation and chronic obstructive pulmonary disease: the role of outcome studies
Source: Eur Respir J 2015; 46: 8-10
Year: 2015
Investigating the fatigue and related factors in patients with chronic obstructive pulmonary disease.
Source: International Congress 2017 – Assessing functional outcomes in chronic respiratory disease
Year: 2017
Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly
Source: Eur Respir J 2003; 21: 3S-9S
Year: 2003
Epigenetic-like regulation of signalling proteins in chronic obstructive pulmonary disease
Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms
Year: 2019
The role of inflamatory markers in obstructive pulmonary disease
Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care
Year: 2012
Mucosal cryobiopsies: A novel method for studying obstructive airways disease?
Source: International Congress 2017 – Innovation in COPD: techniques and facts
Year: 2017
The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Inflammatory cell microlocalisation and airway dysfunction: cause and effect?
Source: Eur Respir J 2007; 30: 1043-1056
Year: 2007
How we can modify the steroid insensitivity in patients with chronic obstructive pulmonary disease? The new pharmacological approach to old problem
Source: Annual Congress 2011 - COPD management
Year: 2011
Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?
Source: Eur Respir J 2002; 20: 9S-19S
Year: 2002
Mechanisms of airflow limitation characteristic of obstructive lung disease
Source: Annual Congress 2004 - Simplifying the complexities of obstructive lung disease: Exploring a new therapeutic target
Year: 2004
Are severe asthma and chronic obstructive pulmonary disease the same disease?
Source: Annual Congress 2006 - Smoking asthmatics – a neglected population?
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept